TERUMO CARDIOVASCULAR SYSTEMS CORP.
History
| Year | Detail |
|---|---|
| 1999 | Terumo Corporation acquired the Sarns and CDI brands from 3M and merged the technologies with CAPIOX to form Terumo Cardiovascular Systems. |
| 2000 | Terumo Cardiovascular Systems introduced the CAPIOX RX Oxygenator. |
| 2001 | The company has entered an exclusive distribution agreement with Pall Corporation for cardiovascular filters. |
| 2002 | It has acquired Vascutek Ltd., a global leader in artificial vascular grafts, and launched the CAPIOX Baby RX (RX05) Neonatal Oxygenator. |
| 2003 | Introduced Terumo Advanced Perfusion System 1. |
| 2006 | Terumo Cardiovascular Systems entered into an exclusive distribution agreement with Harvest Technologies Corporation to distribute SmartPrep platelet gel therapy in the North American cardiovascular market. |
| 2007 | The company has become the exclusive distributor of Vascutek Vascular Grafts in the United States. |
| 2008 | Introduced CAPIOX FX Oxygenator, the industry’s first oxygenator with an integrated arterial filter, and CAPIOX FX05 Oxygenator, the industry’s first pediatric oxygenator with an integrated arterial filter. |
| 2012 | Terumo Cardiovascular Group acquired the Orpheus Perfusion Simulation technology from Ulco Technologies. |
| 2013 | Terumo Cardiovascular Group was formed, creating a global headquarters focused on the needs of cardiac surgery teams worldwide. Terumo Cardiovascular Group acquired the beating heart and stabilization technologies from Estech Cardiothoracic Stabilization Technologies. |
| 2014 | It has become the exclusive distributor of Nonin Medical’s SenSmart Model X-100 in the United States. |
| 2016 | The company has introduced CAPIOX FX Advance Oxygenator, further reducing prime volume and lowering hemodilution. |
| 2018 | 510(k) clearance received for the CDI Blood Parameter Monitoring System 550, adding new parameter for oxygen delivery. |
| 2019 | Terumo Cardiovascular Group and Talis Clinical announced a partnership to deliver intelligent, real-time guidance to CVOR and CVICU to improve outcomes. |
| 2019 | Terumo Cardiovascular Group and Hemostasis introduce BoneSeal Bone Hemostat. |
BCC Research Beacon